{"count": 27, "results": [{"_id": "37485200", "pmid": 37485200, "pmcid": "PMC10359143", "title": "Potential Ketoacidosis Linked to Imeglimin and Metformin Co-administration in a Patient With Type 2 Diabetes", "journal": "Cureus", "authors": ["Yamagishi H", "Hoshino S", "Hirano A", "Oshima A", "Imai T"], "date": "2023-06-20T00:00:00Z", "doi": "10.7759/cureus.40702", "meta_date_publication": "2023 Jun", "meta_volume": "15", "meta_issue": "6", "meta_pages": "e40702", "score": 50278.8, "text_hl": "Therefore, the combination of @CHEMICAL_imeglimin @CHEMICAL_MESH:C575881 @@@imeglimin@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ might have precipitated the development of @<m>DISEASE_Ketosis</m> @DISEASE_MESH:D007662 @@@ketoacidosis@@@.", "citations": {"NLM": "Yamagishi H, Hoshino S, Hirano A, Oshima A, Imai T. Potential Ketoacidosis Linked to Imeglimin and Metformin Co-administration in a Patient With Type 2 Diabetes Cureus. 2023 Jun;15(6):e40702. PMID: 37485200", "BibTeX": "@article{37485200, title={Potential Ketoacidosis Linked to Imeglimin and Metformin Co-administration in a Patient With Type 2 Diabetes}, author={Yamagishi H and Hoshino S and Hirano A and Oshima A and Imai T}, journal={Cureus}, volume={15}, number={6}, pages={e40702}}"}}, {"_id": "39677160", "pmid": 39677160, "title": "A Rare Case of Metformin-Induced Lactic Acidosis and Concomitant Euglycemic Ketoacidosis.", "journal": "Cureus", "authors": ["Shiplett A", "Mathias J"], "date": "2024-11-14T00:00:00Z", "doi": "10.7759/cureus.73708", "meta_date_publication": "2024 Nov", "meta_volume": "16", "meta_issue": "11", "meta_pages": "e73708", "score": 50272.87, "text_hl": "A Rare Case of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-Induced @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@Lactic Acidosis@@@ and Concomitant @<m>DISEASE_Ketosis</m> @DISEASE_MESH:D007662 @@@Euglycemic Ketoacidosis@@@.", "citations": {"NLM": "Shiplett A, Mathias J. A Rare Case of Metformin-Induced Lactic Acidosis and Concomitant Euglycemic Ketoacidosis. Cureus. 2024 Nov;16(11):e73708. PMID: 39677160", "BibTeX": "@article{39677160, title={A Rare Case of Metformin-Induced Lactic Acidosis and Concomitant Euglycemic Ketoacidosis.}, author={Shiplett A and Mathias J}, journal={Cureus}, volume={16}, number={11}, pages={e73708}}"}}, {"_id": "40270662", "pmid": 40270662, "title": "Mottling as an Early Sign of Euglycemic Ketoacidosis Induced by SGLT-2 Inhibitors.", "journal": "Eur J Case Rep Intern Med", "authors": ["Memeti B", "Brombacher F", "Perger L", "Russmann S"], "date": "2025-03-21T00:00:00Z", "doi": "10.12890/2025_005210", "meta_date_publication": "2025", "meta_volume": "12", "meta_issue": "4", "meta_pages": "005210", "score": 50262.266, "text_hl": "Mottling as an Early Sign of @<m>DISEASE_Ketosis</m> @DISEASE_MESH:D007662 @@@Euglycemic Ketoacidosis@@@ Induced by @GENE_SLC5A2 @GENE_6524 @@@SGLT-2@@@ Inhibitors.", "citations": {"NLM": "Memeti B, Brombacher F, Perger L, Russmann S. Mottling as an Early Sign of Euglycemic Ketoacidosis Induced by SGLT-2 Inhibitors. Eur J Case Rep Intern Med. 2025;12(4):005210. PMID: 40270662", "BibTeX": "@article{40270662, title={Mottling as an Early Sign of Euglycemic Ketoacidosis Induced by SGLT-2 Inhibitors.}, author={Memeti B and Brombacher F and Perger L and Russmann S}, journal={Eur J Case Rep Intern Med}, volume={12}, number={4}, pages={005210}}"}}, {"_id": "36934381", "pmid": 36934381, "title": "Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose.", "journal": "CEN Case Rep", "authors": ["Kuno H", "Fujimaru T", "Kadota N", "Konishi K", "Sekiguchi M", "Watanabe K", "Ito Y", "Nagahama M", "Taki F", "Hifumi T", "Otani N", "Nakayama M"], "date": "2023-03-19T00:00:00Z", "doi": "10.1007/s13730-023-00783-w", "meta_date_publication": "2023 Mar 19", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50248.19, "text_hl": "We propose that not only @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@ but also @<m>DISEASE_Ketosis</m> @DISEASE_MESH:D007662 @@@ketoacidosis@@@ is one of the important pathological conditions in @SPECIES_9606 @@@patients@@@ with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ @DISEASE_Drug_Overdose @DISEASE_MESH:D062787 @@@overdose@@@.", "citations": {"NLM": "Kuno H, Fujimaru T, Kadota N, Konishi K, Sekiguchi M, Watanabe K, Ito Y, Nagahama M, Taki F, Hifumi T, Otani N, Nakayama M. Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose. CEN Case Rep. 2023 Mar 19;():. PMID: 36934381", "BibTeX": "@article{36934381, title={Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose.}, author={Kuno H and Fujimaru T and Kadota N and Konishi K and Sekiguchi M and Watanabe K and Ito Y and Nagahama M and Taki F and Hifumi T and Otani N and Nakayama M}, journal={CEN Case Rep}}"}}, {"_id": "40416155", "pmid": 40416155, "title": "Shared Pathogenic Features Between Serotonin Receptor Antagonist-Associated Diabetic Ketosis and Ketosis-Prone Type 2 Diabetes: A Case Report.", "journal": "Cureus", "authors": ["Nakanishi S", "Sato H", "Oikawa Y", "Ikebukuro K", "Shimada A"], "date": "2025-04-23T00:00:00Z", "doi": "10.7759/cureus.82833", "meta_date_publication": "2025 Apr", "meta_volume": "17", "meta_issue": "4", "meta_pages": "e82833", "score": 50247.344, "text_hl": "@DISEASE_Diabetes_Mellitus_Type_1 @DISEASE_MESH:D003922 @@@Ketosis-prone type 2 diabetes@@@ (@DISEASE_Diabetes_Mellitus_Type_1 @DISEASE_MESH:D003922 @@@KPD@@@) is characterized by male predominance, onset at a young age, @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@, and sudden onset of @DISEASE_Diabetic_Ketoacidosis @DISEASE_MESH:D016883 @@@diabetic ketosis@@@/@<m>DISEASE_Ketosis</m> @DISEASE_MESH:D007662 @@@ketoacidosis@@@ without precipitating factors, negative anti-islet autoantibodies, and beta-cell function preservation after recovery from @DISEASE_Diabetic_Ketoacidosis @DISEASE_MESH:D016883 @@@diabetic ketosis@@@/@<m>DISEASE_Ketosis</m> @DISEASE_MESH:D007662 @@@ketoacidosis@@@ following temporal @CHEMICAL_Insulin @CHEMICAL_MESH:D007328 @@@insulin@@@ therapy. ", "citations": {"NLM": "Nakanishi S, Sato H, Oikawa Y, Ikebukuro K, Shimada A. Shared Pathogenic Features Between Serotonin Receptor Antagonist-Associated Diabetic Ketosis and Ketosis-Prone Type 2 Diabetes: A Case Report. Cureus. 2025 Apr;17(4):e82833. PMID: 40416155", "BibTeX": "@article{40416155, title={Shared Pathogenic Features Between Serotonin Receptor Antagonist-Associated Diabetic Ketosis and Ketosis-Prone Type 2 Diabetes: A Case Report.}, author={Nakanishi S and Sato H and Oikawa Y and Ikebukuro K and Shimada A}, journal={Cureus}, volume={17}, number={4}, pages={e82833}}"}}, {"_id": "35884947", "pmid": 35884947, "pmcid": "PMC9313150", "title": "Metformin Is Associated with the Inhibition of Renal Artery AT1R/ET-1/iNOS Axis in a Rat Model of Diabetic Nephropathy with Suppression of Inflammation and Oxidative Stress and Kidney Injury", "journal": "Biomedicines", "authors": ["Dawood AF", "Maarouf A", "Alzamil NM", "Momenah MA", "Shati AA", "Bayoumy NM", "Kamar SS", "Haidara MA", "ShamsEldeen AM", "Yassin HZ", "Hewett PW", "Al-Ani B"], "date": "2022-07-08T00:00:00Z", "doi": "10.3390/biomedicines10071644", "meta_date_publication": "2022 Jul 8", "meta_volume": "10", "meta_issue": "7", "meta_pages": "", "score": 50246.17, "text_hl": "@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@ significantly (p < 0.0001) modulated renal artery tissue levels of @GENE_AGTR1A @GENE_24180 @@@AT1R@@@, @GENE_EDN1 @GENE_24323 @@@ET-1@@@, @GENE_NOS2 @GENE_24599 @@@inducible nitric oxide synthase@@@ (@GENE_NOS2 @GENE_24599 @@@iNOS@@@), @GENE_NOS3 @GENE_24600 @@@endothelial NOS@@@ (@GENE_NOS3 @GENE_24600 @@@eNOS@@@), and the @DISEASE_Sleep_Disorders_Circadian_Rhythm @DISEASE_MESH:D020178 @@@advanced glycation@@@ end products that were protected by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. In addition, @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@-induced @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@, oxidative stress, @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, @<m>DISEASE_Ketosis</m> @DISEASE_MESH:D007662 @@@ketonuria@@@, mesangial matrix expansion, and kidney collagen were significantly reduced by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Dawood AF, Maarouf A, Alzamil NM, Momenah MA, Shati AA, Bayoumy NM, Kamar SS, Haidara MA, ShamsEldeen AM, Yassin HZ, Hewett PW, Al-Ani B. Metformin Is Associated with the Inhibition of Renal Artery AT1R/ET-1/iNOS Axis in a Rat Model of Diabetic Nephropathy with Suppression of Inflammation and Oxidative Stress and Kidney Injury Biomedicines. 2022 Jul 8;10(7):. PMID: 35884947", "BibTeX": "@article{35884947, title={Metformin Is Associated with the Inhibition of Renal Artery AT1R/ET-1/iNOS Axis in a Rat Model of Diabetic Nephropathy with Suppression of Inflammation and Oxidative Stress and Kidney Injury}, author={Dawood AF and Maarouf A and Alzamil NM and Momenah MA and Shati AA and Bayoumy NM and Kamar SS and Haidara MA and ShamsEldeen AM and Yassin HZ and Hewett PW and Al-Ani B}, journal={Biomedicines}, volume={10}, number={7}}"}}, {"_id": "32699722", "pmid": 32699722, "pmcid": "PMC7370668", "title": "Metformin Associated Lactic Acidosis in the Intensive Care Unit: A Rare Condition Mimicking Sepsis", "journal": "Cureus", "authors": ["Sendil S", "Yarlagadda K", "Lawal H", "Nookala V", "Shingala H"], "date": "2020-07-10T00:00:00Z", "doi": "10.7759/cureus.9119", "meta_date_publication": "2020 Jul 10", "meta_volume": "12", "meta_issue": "7", "meta_pages": "e9119", "score": 50244.633, "text_hl": "@DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@MALA@@@ can occur any time a @SPECIES_9606 @@@patient@@@ on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ suffers disruption in renal function resulting in the accumulation of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Sendil S, Yarlagadda K, Lawal H, Nookala V, Shingala H. Metformin Associated Lactic Acidosis in the Intensive Care Unit: A Rare Condition Mimicking Sepsis Cureus. 2020 Jul 10;12(7):e9119. PMID: 32699722", "BibTeX": "@article{32699722, title={Metformin Associated Lactic Acidosis in the Intensive Care Unit: A Rare Condition Mimicking Sepsis}, author={Sendil S and Yarlagadda K and Lawal H and Nookala V and Shingala H}, journal={Cureus}, volume={12}, number={7}, pages={e9119}}"}}, {"_id": "34195559", "pmid": 34195559, "pmcid": "PMC8240148", "title": "Glycemic Outcomes of Second-Line Diabetes Drug Choice in a Real-World Population", "journal": "Mayo Clin Proc Innov Qual Outcomes", "authors": ["Wallia A", "O'Brien MJ", "Liss DT", "Kang RH", "Cooper AJ", "Gilmer A", "Ackermann RT"], "date": "2021-05-26T00:00:00Z", "doi": "10.1016/j.mayocpiqo.2021.02.008", "meta_date_publication": "2021 Jun", "meta_volume": "5", "meta_issue": "3", "meta_pages": "675-681", "score": 50241.8, "text_hl": "@DISEASE_Hypoglycemia @DISEASE_MESH:D007003 @@@Hypoglycemia and@@@ @DISEASE_Acute_Disease @DISEASE_MESH:D000208 @@@acute metabolic complications@@@ (@DISEASE_Acute_Disease @DISEASE_MESH:D000208 @@@AMCs@@@; @<m>DISEASE_Ketosis</m> @DISEASE_MESH:D007662 @@@ketoacidosis@@@, @DISEASE_Hyperglycemic_Hyperosmolar_Nonketotic_Coma @DISEASE_MESH:D006944 @@@hyperosmolarity@@@, and @DISEASE_Coma @DISEASE_MESH:D003128 @@@coma@@@) are glycemic outcomes that have high cost and high morbidity; these outcomes must be taken into consideration when choosing initial second-line therapy after @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Wallia A, O'Brien MJ, Liss DT, Kang RH, Cooper AJ, Gilmer A, Ackermann RT. Glycemic Outcomes of Second-Line Diabetes Drug Choice in a Real-World Population Mayo Clin Proc Innov Qual Outcomes. 2021 Jun;5(3):675-681. PMID: 34195559", "BibTeX": "@article{34195559, title={Glycemic Outcomes of Second-Line Diabetes Drug Choice in a Real-World Population}, author={Wallia A and O'Brien MJ and Liss DT and Kang RH and Cooper AJ and Gilmer A and Ackermann RT}, journal={Mayo Clin Proc Innov Qual Outcomes}, volume={5}, number={3}, pages={675-681}}"}}, {"_id": "32413342", "pmid": 32413342, "pmcid": "PMC7217100", "title": "COVID-19 in diabetic patients: Related risks and specifics of management", "journal": "Ann Endocrinol (Paris)", "authors": ["Orioli L", "Hermans MP", "Thissen JP", "Maiter D", "Vandeleene B", "Yombi JC"], "date": "2020-06-01T00:00:00Z", "doi": "10.1016/j.ando.2020.05.001", "meta_date_publication": "2020 Jun", "meta_volume": "81", "meta_issue": "2-3", "meta_pages": "101-109", "score": 50241.43, "text_hl": "There are currently no recommendations in favour of discontinuing antihypertensive medications that interact with the @GENE_REN @GENE_5972 @@@renin@@@-angiotensin-@CHEMICAL_Aldosterone @CHEMICAL_MESH:D000450 @@@aldosterone@@@ system. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and SGLT2 inhibitors should be discontinued in @SPECIES_9606 @@@patients@@@ with severe forms of @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@ owing to the risks of @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@ and @<m>DISEASE_Ketosis</m> @DISEASE_MESH:D007662 @@@ketoacidosis@@@. ", "citations": {"NLM": "Orioli L, Hermans MP, Thissen JP, Maiter D, Vandeleene B, Yombi JC. COVID-19 in diabetic patients: Related risks and specifics of management Ann Endocrinol (Paris). 2020 Jun;81(2-3):101-109. PMID: 32413342", "BibTeX": "@article{32413342, title={COVID-19 in diabetic patients: Related risks and specifics of management}, author={Orioli L and Hermans MP and Thissen JP and Maiter D and Vandeleene B and Yombi JC}, journal={Ann Endocrinol (Paris)}, volume={81}, number={2-3}, pages={101-109}}"}}, {"_id": "37313364", "pmid": 37313364, "pmcid": "PMC10259106", "title": "A Diagnostic Dilemma \"Cured\" by Dialysis: An Educational Case Report", "journal": "Can J Kidney Health Dis", "authors": ["Chan RJ", "McCudden C", "McCormick B", "Zimmerman D"], "date": "2023-06-01T00:00:00Z", "doi": "10.1177/20543581231177841", "meta_date_publication": "2023", "meta_volume": "10", "meta_issue": "", "meta_pages": "20543581231177841", "score": 50239.65, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@Toxicity@@@", "citations": {"NLM": "Chan RJ, McCudden C, McCormick B, Zimmerman D. A Diagnostic Dilemma \"Cured\" by Dialysis: An Educational Case Report Can J Kidney Health Dis. 2023;10():20543581231177841. PMID: 37313364", "BibTeX": "@article{37313364, title={A Diagnostic Dilemma \"Cured\" by Dialysis: An Educational Case Report}, author={Chan RJ and McCudden C and McCormick B and Zimmerman D}, journal={Can J Kidney Health Dis}, volume={10}, pages={20543581231177841}}"}}]}